Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Vanderbilt ADHD Diagnostic Parent Rating Scale
1
x
$
0.00
Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder
1
x
$
30.00
Farmacoterapias: Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
1
x
$
0.00
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
Takefumi Suzuki - Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
1
x
$
30.00
A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario
1
x
$
30.00
Xin-Yun Lu, PhD, MD: Role of Central Melanocortin Signaling in Eating Disorders
1
x
$
30.00
Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
1
x
$
30.00
Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges
1
x
$
30.00
Jane P. Gagliardi, MD: Treatment of Thyrotoxicosis-Induced Psychosis
1
x
$
30.00
Ziprasidone Induced Tardive Cervical Dystonia
1
x
$
30.00
Why Do Persons with Bipolar Disorder Stop Their Medication?
1
x
$
30.00
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
1
x
$
30.00
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
1
x
$
30.00
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine
1
x
$
30.00
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
1
x
$
30.00
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
1
x
$
30.00
View Cart
Checkout
Home
IV Bure
“Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
$
30.00
Add to cart
Details
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
